Skip to main content

Clinical Trials › NCT06592352

RecruitingPhase 2

MODAFIMS: A Trial to Evaluate Predictors of Response to MODAFinil in Patients With Multiple Sclerosis

Sponsored by Clinical Academic Center (2CA-Braga)

Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov
64
Target enrollment
Aug 2024
Start date
Sep 2026
Expected completion

Interventions / Treatments

Modafinil Generis 100 mg

Conditions studied

Multiple Sclerosis

Trial locations

U.S. site locations haven't been posted yet for this trial. Check ClinicalTrials.gov for the latest contact and location info.

More Phase 2 trials

Browse all Phase 2 MS trials
The app

Check out the MS Buddy app

Track symptoms, monitor wellness, and stay on top of your MS care. It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play